Aptose Biosciences Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptose biosciences company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptose Biosciences Company Profile Today - Breaking & Trending Today

Aptose Biosciences (NASDAQ:APTO) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Several other analysts also recently commented on APTO. HC Wainwright reaffirmed a “buy” rating and set a $23.00 […] ....

United States , Piper Sandler , Aptose Biosciences , Aptose Biosciences Company Profile , Canaccord Genuity Group , Aptose Biosciences Inc , Texas Capital Bank Wealth Management Services Inc , Annandale Capital , Sigma Planning Corp , Get Free Report , Genuity Group , Capital Bank Wealth Management Services Inc , Biosciences Inc , Aptose Biosciences Daily ,

Aptose Biosciences (TSE:APS) Hits New 1-Year Low at $1.36

Aptose Biosciences (TSE:APS) Hits New 1-Year Low at $1.36
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Aptose Biosciences , Aptose Biosciences Company Profile , Aptose Biosciences Inc , Get Free Report , Biosciences Stock Down , Biosciences Inc , Aptose Biosciences Daily ,

Aptose Biosciences (NASDAQ:APTO) Now Covered by Analysts at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a report released on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock. Other analysts also recently issued research reports about the company. Piper Sandler reaffirmed an “overweight” rating and issued a $5.00 price […] ....

United States , Piper Sandler , Aptose Biosciences , Sigma Planning Corp , Aptose Biosciences Inc , Aptose Biosciences Company Profile , Canaccord Genuity Group , Annandale Capital , Texas Capital Bank Wealth Management Services Inc , Get Free Report , Capital Bank Wealth Management Services Inc , Biosciences Inc , Aptose Biosciences Daily ,

Aptose Biosciences (NASDAQ:APTO) Price Target Lowered to $6.00 at Canaccord Genuity Group

Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) had its target price cut by Canaccord Genuity Group from $15.00 to $6.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Canaccord Genuity Group’s target price would suggest a potential upside of […] ....

United States , Piper Sandler , Aptose Biosciences , Aptose Biosciences Inc , Texas Capital Bank Wealth Management Services Inc , Sigma Planning Corp , Annandale Capital , Canaccord Genuity Group , Aptose Biosciences Company Profile , Get Free Report , Genuity Group , Capital Bank Wealth Management Services Inc , Biosciences Inc , Aptose Biosciences Daily ,

Canaccord Genuity Group Trims Aptose Biosciences (NASDAQ:APTO) Target Price to $6.00

Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) had its price target dropped by equities researchers at Canaccord Genuity Group from $15.00 to $6.00 in a report released on Thursday, Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Canaccord Genuity Group’s price target would indicate a potential upside of […] ....

United States , Aptose Biosciences , Piper Sandler , Canaccord Genuity Group , Annandale Capital , Aptose Biosciences Company Profile , Aptose Biosciences Inc , Texas Capital Bank Wealth Management Services Inc , Sigma Planning Corp , Get Free Report , Genuity Group , Capital Bank Wealth Management Services Inc , Biosciences Inc , Aptose Biosciences Daily ,